During the last session, Oramed Pharmaceuticals, Inc (NASDAQ:ORMP)’s traded shares were 0.36 million, with the beta value of the company hitting 1.48. At the end of the trading day, the stock’s price was $2.57, reflecting an intraday gain of 9.36% or $0.22. The 52-week high for the ORMP share is $3.14, that puts it down -22.18 from that peak though still a striking 23.74% gain since the share price plummeted to a 52-week low of $1.96. The company’s market capitalization is $103.60M, and the average trade volume was 284.38K shares over the past three months.
Oramed Pharmaceuticals, Inc (ORMP) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. ORMP has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Oramed Pharmaceuticals, Inc (NASDAQ:ORMP) trade information
Oramed Pharmaceuticals, Inc (ORMP) registered a 9.36% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 9.36% in intraday trading to $2.57, hitting a weekly high. The stock’s 5-day price performance is 22.97%, and it has moved by 17.35% in 30 days. Based on these gigs, the overall price performance for the year is -21.17%.
While earnings are projected to return 50.00% in 2025.
ORMP Dividends
Oramed Pharmaceuticals, Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 1.35 million shares, is of BML CAPITAL MANAGEMENT, LLC’s that is approximately 3.2936% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $3.47 million.
Also, the Mutual Funds coming in first place with the largest holdings of Oramed Pharmaceuticals, Inc (ORMP) shares are RBC Fds Tr-RBC Micro Cap Value Fd and iShares Micro Cap ETF . Data provided on Dec 31, 2024 indicates that RBC Fds Tr-RBC Micro Cap Value Fd owns about 85.3 shares. This amounts to just over 0.21 percent of the company’s overall shares, with a $0.22 million market value. The same data shows that the other fund manager holds slightly less at 85.81, or about 0.21% of the stock, which is worth about $0.22 million.
